Related Experiment Video
Updated: Oct 4, 2025

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Maladaptive functional changes in alveolar fibroblasts due to perinatal hyperoxia impair epithelial differentiation
Matthew R Riccetti1,2, Mereena George Ushakumary1, Marion Waltamath1
1The Perinatal Institute and Section of Neonatology, Perinatal and Pulmonary Biology, and.
Insights
Bronchopulmonary dysplasia (BPD) in premature infants involves fibroblast changes. Hyperoxia impairs PDGFRA+ fibroblasts, affecting lung development, but WNT activation may restore function.
Area of Science:
- Pulmonary Medicine
- Developmental Biology
- Cell Biology
Background:
- Bronchopulmonary dysplasia (BPD) affects up to 50% of premature infants, characterized by impaired lung alveolarization and microvascular development.
- PDGFRA+ fibroblasts are crucial for lung development, and their reduction is implicated in BPD pathogenesis.
- Understanding fibroblast heterogeneity and activation is key for developing targeted BPD therapies.
Purpose of the Study:
- To investigate the heterogeneity and functional changes of PDGFRA+ fibroblasts during neonatal hyperoxia-induced lung injury and repair.
- To identify therapeutic targets for BPD by analyzing fibroblast responses to hyperoxia.
Main Methods:
- Utilized a neonatal hyperoxia mouse model (90% O2, P0-P7).
- Sorted and analyzed PDGFRA+ fibroblasts during injury and recovery phases.
- Performed in vitro contractility assays and generated lung organoids.
Main Results:
- Hyperoxia decreased PDGFRA+ matrix/myofibroblasts and increased lipofibroblasts; these populations recovered by P10.
- Hyperoxia-exposed PDGFRA+ fibroblasts showed reduced contractility and impaired alveolar type 1 cell differentiation in organoids.
- Pathway analysis revealed reduced WNT signaling in hyperoxia fibroblasts.
- WNT activation in organoids partially restored alveolar development and enhanced type 2 cell differentiation.
Conclusions:
- Neonatal hyperoxia alters PDGFRA+ fibroblast populations and function, impairing lung development.
- Reduced WNT signaling in fibroblasts contributes to BPD-like lung changes.
- Targeting WNT signaling may offer a therapeutic strategy for BPD.
Abstract:
Infants born prematurely worldwide have up to a 50% chance of developing bronchopulmonary dysplasia (BPD), a clinical morbidity characterized by dysregulated lung alveolarization and microvascular development. It is known that PDGFR alpha-positive (PDGFRA+) fibroblasts are critical for alveolarization and that PDGFRA+ fibroblasts are reduced in BPD. A better understanding of fibroblast heterogeneity and functional activation status during pathogenesis is required to develop mesenchymal population-targeted therapies for BPD. In this study, we utilized a neonatal hyperoxia mouse model (90% O2 postnatal days 0-7, PN0-PN7) and performed studies on sorted PDGFRA+ cells during injury and room air recovery. After hyperoxia injury, PDGFRA+ matrix and myofibroblasts decreased and PDGFRA+ lipofibroblasts increased by transcriptional signature and population size. PDGFRA+ matrix and myofibroblasts recovered during repair (PN10). After 7 days of in vivo hyperoxia, PDGFRA+ sorted fibroblasts had reduced contractility in vitro, reflecting loss of myofibroblast commitment. Organoids made with PN7 PDGFRA+ fibroblasts from hyperoxia in mice exhibited reduced alveolar type 1 cell differentiation, suggesting reduced alveolar niche-supporting PDGFRA+ matrix fibroblast function. Pathway analysis predicted reduced WNT signaling in hyperoxia fibroblasts. In alveolar organoids from hyperoxia-exposed fibroblasts, WNT activation by CHIR increased the size and number of alveolar organoids and enhanced alveolar type 2 cell differentiation.
More Related Videos
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Breathing
Alveoli and Alveolar Ducts
Regulation of Angiogenesis and Blood Supply

